Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 44

1.

Race and BMI modify associations of calcium and vitamin D intake with prostate cancer.

Batai K, Murphy AB, Ruden M, Newsome J, Shah E, Dixon MA, Jacobs ET, Hollowell CM, Ahaghotu C, Kittles RA.

BMC Cancer. 2017 Jan 19;17(1):64. doi: 10.1186/s12885-017-3060-8.

2.

Association between Serum 25-Hydroxy-Vitamin D and Aggressive Prostate Cancer in African American Men.

Nelson SM, Batai K, Ahaghotu C, Agurs-Collins T, Kittles RA.

Nutrients. 2016 Dec 28;9(1). pii: E12. doi: 10.3390/nu9010012.

3.

African-American Men with Low-Risk Prostate Cancer: Modern Treatment and Outcome Trends.

Obirieze AC, Moten A, Allen D, Ahaghotu CA.

J Racial Ethn Health Disparities. 2015 Sep;2(3):295-302. doi: 10.1007/s40615-014-0071-x. Epub 2014 Dec 16.

PMID:
26863460
4.

African American Participation in Oncology Clinical Trials--Focus on Prostate Cancer: Implications, Barriers, and Potential Solutions.

Ahaghotu C, Tyler R, Sartor O.

Clin Genitourin Cancer. 2016 Apr;14(2):105-16. doi: 10.1016/j.clgc.2015.12.003. Epub 2015 Dec 17. Review.

PMID:
26786562
5.

Analyzing the Association of Polymorphisms in the CRYBB2 Gene with Prostate Cancer Risk in African Americans.

Faruque MU, Paul R, Ricks-Santi L, Jingwi EY, Ahaghotu CA, Dunston GM.

Anticancer Res. 2015 May;35(5):2565-70.

6.

Ureteral injury after laparoscopic versus open colectomy.

Zafar SN, Ahaghotu CA, Libuit L, Ortega G, Coleman PW, Cornwell EE 3rd, Tran DD, Fullum TM.

JSLS. 2014 Jul-Sep;18(3). pii: e2014.00158. doi: 10.4293/JSLS.2014.00158.

7.

Common vitamin D pathway gene variants reveal contrasting effects on serum vitamin D levels in African Americans and European Americans.

Batai K, Murphy AB, Shah E, Ruden M, Newsome J, Agate S, Dixon MA, Chen HY, Deane LA, Hollowell CM, Ahaghotu C, Kittles RA.

Hum Genet. 2014 Nov;133(11):1395-405. doi: 10.1007/s00439-014-1472-y. Epub 2014 Aug 2.

8.

Smoking and prostate cancer in a multi-ethnic cohort.

Murphy AB, Akereyeni F, Nyame YA, Guy MC, Martin IK, Hollowell CM, Walker K, Kittles RA, Ahaghotu C.

Prostate. 2013 Oct;73(14):1518-28. doi: 10.1002/pros.22699. Epub 2013 Jul 3.

9.

Recurrent subacute post-viral onset of ataxia associated with a PRF1 mutation.

Dias C, McDonald A, Sincan M, Rupps R, Markello T, Salvarinova R, Santos RF, Menghrajani K, Ahaghotu C, Sutherland DP, Fortuno ES 3rd, Kollmann TR, Demos M, Friedman JM, Speert DP, Gahl WA, Boerkoel CF.

Eur J Hum Genet. 2013 Nov;21(11):1232-9. doi: 10.1038/ejhg.2013.20. Epub 2013 Feb 27.

10.

Scrotal mass and unilateral lung masses with pleural effusion mimicking metastatic testicular malignancy: an unusual presentation of sarcoidosis.

Esnakula AK, Coleman P, Ahaghotu CA, Naab TJ.

BMJ Case Rep. 2013 Feb 15;2013. pii: bcr2012008658. doi: 10.1136/bcr-2013-008658.

11.

Fostering informed decisions: a randomized controlled trial assessing the impact of a decision aid among men registered to undergo mass screening for prostate cancer.

Williams RM, Davis KM, Luta G, Edmond SN, Dorfman CS, Schwartz MD, Lynch J, Ahaghotu C, Taylor KL.

Patient Educ Couns. 2013 Jun;91(3):329-36. doi: 10.1016/j.pec.2012.12.013. Epub 2013 Jan 26.

12.

Fine-mapping of IL16 gene and prostate cancer risk in African Americans.

Batai K, Shah E, Murphy AB, Newsome J, Ruden M, Ahaghotu C, Kittles RA.

Cancer Epidemiol Biomarkers Prev. 2012 Nov;21(11):2059-68. doi: 10.1158/1055-9965.EPI-12-0707. Epub 2012 Aug 24.

13.

Identification of genetic risk associated with prostate cancer using ancestry informative markers.

Ricks-Santi LJ, Apprey V, Mason T, Wilson B, Abbas M, Hernandez W, Hooker S, Doura M, Bonney G, Dunston G, Kittles R, Ahaghotu C.

Prostate Cancer Prostatic Dis. 2012 Dec;15(4):359-64. doi: 10.1038/pcan.2012.19. Epub 2012 Jul 17.

14.

Recombination mapping using Boolean logic and high-density SNP genotyping for exome sequence filtering.

Markello TC, Han T, Carlson-Donohoe H, Ahaghotu C, Harper U, Jones M, Chandrasekharappa S, Anikster Y, Adams DR; NISC Comparative Sequencing Program, Gahl WA, Boerkoel CF.

Mol Genet Metab. 2012 Mar;105(3):382-9. doi: 10.1016/j.ymgme.2011.12.014. Epub 2011 Dec 23.

15.

p53 Pro72Arg polymorphism and prostate cancer in men of African descent.

Ricks-Santi L, Mason T, Apprey V, Ahaghotu C, McLauchlin A, Josey D, Bonney G, Dunston GM.

Prostate. 2010 Dec 1;70(16):1739-45. doi: 10.1002/pros.21209.

16.

Underuse of colorectal cancer screening among men screened for prostate cancer: a teachable moment?

Red SN, Kassan EC, Williams RM, Penek S, Lynch J, Ahaghotu C, Taylor KL.

Cancer. 2010 Oct 15;116(20):4703-10. doi: 10.1002/cncr.25229.

17.

The association of plasma fatty acids with prostate cancer risk in African Americans and Africans.

Ukoli FA, Fowke JH, Akumabor P, Oguike T, Taher KA, Murff HJ, Amaefuna ER, Kittles R, Ahaghotu C, Osime U, Beech DJ.

J Health Care Poor Underserved. 2010 Feb;21(1 Suppl):127-47. doi: 10.1353/hpu.0.0242.

PMID:
20173289
18.

Replication of prostate cancer risk loci on 8q24, 11q13, 17q12, 19q33, and Xp11 in African Americans.

Hooker S, Hernandez W, Chen H, Robbins C, Torres JB, Ahaghotu C, Carpten J, Kittles RA.

Prostate. 2010 Feb 15;70(3):270-5. doi: 10.1002/pros.21061.

PMID:
19902474
19.

Association of CD14 variant with prostate cancer in African American men.

Mason TE, Ricks-Santi L, Chen W, Apprey V, Joykutty J, Ahaghotu C, Kittles R, Bonney G, Dunston GM.

Prostate. 2010 Feb 15;70(3):262-9. doi: 10.1002/pros.21060.

20.

Psychosocial factors influence parental decision for circumcision in pediatric males of African American descent.

Ahaghotu C, Okafor H, Igiehon E, Gray E.

J Natl Med Assoc. 2009 Apr;101(4):325-30.

PMID:
19397222
21.

Association of HPC2/ELAC2 and RNASEL non-synonymous variants with prostate cancer risk in African American familial and sporadic cases.

Robbins CM, Hernandez W, Ahaghotu C, Bennett J, Hoke G, Mason T, Pettaway CA, Vijayakumar S, Weinrich S, Furbert-Harris P, Dunston G, Powell IJ, Carpten JD, Kittles RA.

Prostate. 2008 Dec 1;68(16):1790-7. doi: 10.1002/pros.20841.

22.

Structural changes in the cervical facet capsular ligament: potential contributions to pain following subfailure loading.

Quinn KP, Lee KE, Ahaghotu CC, Winkelstein BA.

Stapp Car Crash J. 2007 Oct;51:169-87.

PMID:
18278597
23.

NAT2 and NER genetic variants and sporadic prostate cancer susceptibility in African Americans.

Hooker S, Bonilla C, Akereyeni F, Ahaghotu C, Kittles RA.

Prostate Cancer Prostatic Dis. 2008;11(4):349-56. Epub 2007 Nov 20.

PMID:
18026184
24.

Confirmation study of prostate cancer risk variants at 8q24 in African Americans identifies a novel risk locus.

Robbins C, Torres JB, Hooker S, Bonilla C, Hernandez W, Candreva A, Ahaghotu C, Kittles R, Carpten J.

Genome Res. 2007 Dec;17(12):1717-22. Epub 2007 Oct 31.

25.

IGF-1 and IGFBP-3 gene variants influence on serum levels and prostate cancer risk in African-Americans.

Hernandez W, Grenade C, Santos ER, Bonilla C, Ahaghotu C, Kittles RA.

Carcinogenesis. 2007 Oct;28(10):2154-9. Epub 2007 Aug 27.

PMID:
17724372
26.

Genome-wide linkage of 77 families from the African American Hereditary Prostate Cancer study (AAHPC).

Baffoe-Bonnie AB, Kittles RA, Gillanders E, Ou L, George A, Robbins C, Ahaghotu C, Bennett J, Boykin W, Hoke G, Mason T, Pettaway C, Vijayakumar S, Weinrich S, Jones MP, Gildea D, Riedesel E, Albertus J, Moses T, Lockwood E, Klaric M, Faruque M, Royal C, Trent JM, Berg K, Collins FS, Furbert-Harris PM, Bailey-Wilson JE, Dunston GM, Powell I, Carpten JD.

Prostate. 2007 Jan 1;67(1):22-31.

PMID:
17031815
27.

ICAM gene cluster SNPs and prostate cancer risk in African Americans.

Chen H, Hernandez W, Shriver MD, Ahaghotu CA, Kittles RA.

Hum Genet. 2006 Aug;120(1):69-76. Epub 2006 May 30.

PMID:
16733712
28.

Germline BCL-2 sequence variants and inherited predisposition to prostate cancer.

Kidd LR, Coulibaly A, Templeton TM, Chen W, Long LO, Mason T, Bonilla C, Akereyeni F, Freeman V, Isaacs W, Ahaghotu C, Kittles RA.

Prostate Cancer Prostatic Dis. 2006;9(3):284-92. Epub 2006 May 30.

PMID:
16733517
29.

Blockers of the delayed-rectifier potassium current in pancreatic beta-cells enhance glucose-dependent insulin secretion.

Herrington J, Zhou YP, Bugianesi RM, Dulski PM, Feng Y, Warren VA, Smith MM, Kohler MG, Garsky VM, Sanchez M, Wagner M, Raphaelli K, Banerjee P, Ahaghotu C, Wunderler D, Priest BT, Mehl JT, Garcia ML, McManus OB, Kaczorowski GJ, Slaughter RS.

Diabetes. 2006 Apr;55(4):1034-42. Erratum in: Diabetes. 2006 Jun;55(6):1904.

30.

E-cadherin polymorphisms and haplotypes influence risk for prostate cancer.

Bonilla C, Mason T, Long L, Ahaghotu C, Chen W, Zhao A, Coulibaly A, Bennett F, Aiken W, Tullock T, Coard K, Freeman V, Kittles RA.

Prostate. 2006 Apr 1;66(5):546-56.

PMID:
16372334
31.

A common nonsense mutation in EphB2 is associated with prostate cancer risk in African American men with a positive family history.

Kittles RA, Baffoe-Bonnie AB, Moses TY, Robbins CM, Ahaghotu C, Huusko P, Pettaway C, Vijayakumar S, Bennett J, Hoke G, Mason T, Weinrich S, Trent JM, Collins FS, Mousses S, Bailey-Wilson J, Furbert-Harris P, Dunston G, Powell IJ, Carpten JD.

J Med Genet. 2006 Jun;43(6):507-11. Epub 2005 Sep 9.

32.

Sequence variation within the 5' regulatory regions of the vitamin D binding protein and receptor genes and prostate cancer risk.

Kidd LC, Paltoo DN, Wang S, Chen W, Akereyeni F, Isaacs W, Ahaghotu C, Kittles R.

Prostate. 2005 Aug 1;64(3):272-82.

PMID:
15717311
33.

Tuberculous epididymitis with extensive retroperitoneal and mediastinal involvement.

Oben FT, Wright RD, Ahaghotu CA.

Urology. 2004 Jul;64(1):156-8.

PMID:
15245961
34.

Clinical characteristics of African-American men with hereditary prostate cancer: the AAHPC Study.

Ahaghotu C, Baffoe-Bonnie A, Kittles R, Pettaway C, Powell I, Royal C, Wang H, Vijayakumar S, Bennett J, Hoke G, Mason T, Bailey-Wilson J, Boykin W, Berg K, Carpten J, Weinrich S, Trent J, Dunston G, Collins F.

Prostate Cancer Prostatic Dis. 2004;7(2):165-9.

PMID:
15175665
35.

Prostate cancer screening at National Cancer Institute comprehensive and clinical cancer centers.

Taylor KL, Africano NL, Schwartz M, Cullen J, Ahaghotu C.

J Natl Cancer Inst. 2004 Mar 3;96(5):414-5. No abstract available.

PMID:
14996868
36.

Enrollment of African Americans onto clinical treatment trials: study design barriers.

Adams-Campbell LL, Ahaghotu C, Gaskins M, Dawkins FW, Smoot D, Polk OD, Gooding R, DeWitty RL.

J Clin Oncol. 2004 Feb 15;22(4):730-4.

PMID:
14966098
37.

COX-2 gene promoter haplotypes and prostate cancer risk.

Panguluri RC, Long LO, Chen W, Wang S, Coulibaly A, Ukoli F, Jackson A, Weinrich S, Ahaghotu C, Isaacs W, Kittles RA.

Carcinogenesis. 2004 Jun;25(6):961-6. Epub 2004 Jan 30.

PMID:
14754878
38.

African-American heredity prostate cancer study: a model for genetic research.

Powell IJ, Carpten J, Dunston G, Kittles R, Bennett J, Hoke G, Pettaway C, Weinrich S, Vijayakumar S, Ahaghotu CA, Boykin W, Mason T, Royal C, Baffoe-Bonnie A, Bailey-Wilson J, Berg K, Trent J, Collins F.

J Natl Med Assoc. 2001 Apr;93(4):120-3.

39.

CYP3A4-V and prostate cancer in African Americans: causal or confounding association because of population stratification?

Kittles RA, Chen W, Panguluri RK, Ahaghotu C, Jackson A, Adebamowo CA, Griffin R, Williams T, Ukoli F, Adams-Campbell L, Kwagyan J, Isaacs W, Freeman V, Dunston GM.

Hum Genet. 2002 Jun;110(6):553-60. Epub 2002 May 7.

PMID:
12107441
40.

African-American heredity prostate cancer study: a model for genetic research.

Powell IJ, Carpten J, Dunston G, Kittles R, Bennett J, Hoke G, Pettaway C, Weinrich S, Vijayakumar S, Ahaghotu CA, Boykin W, Mason T, Royal C, Baffoe-Bonnie A, Bailey-Wilson J, Berg K, Trent J, Collins F.

J Natl Med Assoc. 2001 Dec;93(12 Suppl):25S-28S.

41.

Cyp17 promoter variant associated with prostate cancer aggressiveness in African Americans.

Kittles RA, Panguluri RK, Chen W, Massac A, Ahaghotu C, Jackson A, Ukoli F, Adams-Campbell L, Isaacs W, Dunston GM.

Cancer Epidemiol Biomarkers Prev. 2001 Sep;10(9):943-7.

42.

Recruitment experience in the first phase of the African American Hereditary Prostate Cancer (AAHPC) study.

Royal C, Baffoe-Bonnie A, Kittles R, Powell I, Bennett J, Hoke G, Pettaway C, Weinrich S, Vijayakumar S, Ahaghotu C, Mason T, Johnson E, Obeikwe M, Simpson C, Mejia R, Boykin W, Roberson P, Frost J, Faison-Smith L, Meegan C, Foster N, Furbert-Harris P, Carpten J, Bailey-Wilson J, Trent J, Berg K, Dunston G, Collins F.

Ann Epidemiol. 2000 Nov;10(8 Suppl):S68-77.

PMID:
11189095
43.
44.

Cellular adhesion molecules in urologic malignancies.

Cohen MB, Griebling TL, Ahaghotu CA, Rokhlin OW, Ross JS.

Am J Clin Pathol. 1997 Jan;107(1):56-63. Review.

PMID:
8980368

Supplemental Content

Loading ...
Support Center